Emergent Biosolutions (EBS) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

EBS is expected to report earnings to fall 90.95% to -20 cents per share on November 06

Emergent Biosolutions EBS Stock Earnings Reports

Q3'24

Est.

$-0.21

Q2'24

Missed

by $1.37

Q1'24

Beat

by $1.42

Q4'23

Missed

by $0.58

Q3'23

Missed

by $0.10

The last earnings report on August 07 showed earnings per share of -231 cents, missing the estimate of -94 cents. With 3.53M shares outstanding, the current market capitalization sits at 120.07M.

View a ticker or compare two or three

Compare

EBS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For EBS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for EBS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a manufacturer of biopharmaceutical products

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Biotechnology

Address

300 Professional Drive

Phone

+1 240 631-3200

Employees

1600

Web

https://www.emergentbiosolutions.com